¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"low lip line"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • low pressure chamber
    Àú¾Ð½Ç
  • low pressure hydrocephalus
    Àú¾Ð¹°³úÁõ, Àú¾Ð¼öµÎÁõ
  • low renin hypertension
    Àú·¹´Ñ°íÇ÷¾Ð
  • low residue diet
    ÀúÀÜ·ùÀ½½Ä
  • low risk group
    ÀúÀ§Ç豺
  • low set ear
    óÁø±Í
  • low signal
    ¾àÇѽÅÈ£, Àú½ÅÈ£
  • low signal intensity
    Àú½ÅÈ£°­µµ
  • low temperature resin
    Àú¿Â¼öÁö
  • low vision aid
    Àú½Ã·Âº¸Á¶±â
  • low-dose tolerance
    Ç׿ø¼Ò·®Çã¿ë
  • low-output heart failure
    Àú¹ÚÃâ½ÉÀå±â´É»ó½Ç, Àú¹ÚÃâ½É(Àå)ºÎÀü
  • low-pass filter
    ÀúÁÖÆÄÅë°ú¿©°ú±â, ÀúÁÖÆÄÅë°ú°Å¸£°³
  • low-purine diet
    ÀúǪ¸°½Ä»ç
  • low-tension glaucoma
    Àú¾È¾Ð³ì³»Àå
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • low-tension glaucoma
    Àú¾È¾Ð³ì³»Àå
  • low pressure hydrocephalus
    Àú¾Ð¹°³úÁõ, Àú¾Ð¼öµÎÁõ
  • low renin hypertension
    Àú·¹´Ñ°íÇ÷¾Ð
  • low birth weight infant
    ÀúüÁßÃâ»ý¾Æ
  • low dose rate irradiation
    Àú¼±·®À²Á¶»ç
  • low signal intensity
    Àú½ÅÈ£°­µµ
  • low signal
    Àú½ÅÈ£, ³·Àº½ÅÈ£
  • low back pain
    ¿äÅë
  • low cervical cesarean section
    ¾Æ·¡ÀڱøñÁ¦¿ÕÀý°³¼ú, ÇϺÎÀڱðæºÎÁ¦¿ÕÀý°³¼ú
  • low dose rate
    Àú¼±·®·ü
  • low field magnetic resonance scanner
    ÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • low temperature resin
    Àú¿Â¼öÁö
  • low-dose tolerance
    Ç׿ø¼Ò·®Çã¿ë
  • low-ionic-strength salt solution
    ÀúÀ̿°­µµ¿°¿ë¾×
  • low-zone tolerance
    Ç׿ø¼Ò·®Çã¿ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Kerleys C line
    Äø® C¼±
  • Kerleys D line
    Äø® D¼±
  • Langer line
    ¶û°Å¼±
  • Mees line
    ¹ÌÁî¼±
  • Sampaolesis line
    »ïÆú·¹½Ã»ö¼Ò¼±
  • Staehlis line
    ½ºÅÚ¸®¼±
  • Stocker line
    ½ºÅåÄ¿¼±
  • Vogts line
    º¸Å©Æ®¼±
  • Voigt line
    Æ÷ÀÌÆ®¼±
  • Z line(=disc)
    Z¼± (ÆÇ)
  • absorption line
    Èí¼ö¼±.
  • alveolar hard line
    Ä¡Á¶°æ¼±(öÍðËÌãàÊ).
  • alveolar ridge line
    Ä¡Á¶Á¤¼±(¡­ð¢àÊ).
  • anocutaneal line
    Ç×¹®ÇǺμ±
  • anocutaneous line
    Ç×¹®ÇǺμ±
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • lateral lip of femur<³ª> labium laterale femoris
    ´ëÅð°ñ ¿ÜÃø ¼ø.
  • lateral lip of femur<³ª> labium laterale femoris
    ´ëÅð°ñ¿ÜÃø¼ø.
  • levator muscle of upper lip ; muscle levator labii superioris
    »ó¼ø°Å±Ù<¾È¿ÍÇϱÙ>.
  • levator muscle of upper lip =muscle levator labii
    »ó¼ø°Å±Ù
  • levator muscle of upper lip and ala of nose =musc
    »ó¼øºñÀͰűÙ
  • levator muscle of upper lip and ala of nose<³ª> musculus levator labii superioris alaeque nasi
    »ó¼øºñÀÍ(ß¾âîÞ¬ìÏ)°Å ±Ù.
  • lip
    ÀÔ¼ú
  • lip
    ±¸¼ø(Ï¢âî)
  • lip
    ±¸¼ø, ÀÔ¼ú{ÇØ}
  • lip
    ÀÔ¼ú, ±¸¼ø.
  • lip
    ÀÔ¼ú
  • lip biting habit
    ±³¼øº®(ÎáâîÛþ).
  • lip cleft
    ±¸¼ø¿­(¡­æñ).
  • lip furrow band
    ¼ø±¸Á¦(âîϵð§).
  • lip of optic cup
    ´«¼úÀܰ¡ÀåÀÚ¸®
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Posterior gluteal line
    µÚº¼±â±Ù¼±
    [¿¾ ¿ë¾î] Èĵбټ±
  • Posterior median line
    µÚÁ¤Áß¼±
    [¿¾ ¿ë¾î] ÈÄÁ¤Áß¼±
  • Trapezoid line
    ¸¶¸§Àδ뼱
    [¿¾ ¿ë¾î] ´ÉÇüÀδ뼱
  • Highest nuchal line
    ¸ÇÀ§¸ñ´ú¹Ì¼±
    [¿¾ ¿ë¾î] ÃÖ»óÇ×(¸ñ´ú¹Ì)¼±
  • Semilunar line
    ¹Ý´Þ¼±
    [¿¾ ¿ë¾î] ¹Ý¿ù¼±
  • Terminal line
    ºÐ°è¼±
    [¿¾ ¿ë¾î] ºÐ°è¼±
  • Midclavicular line
    ºøÀåÁß°£¼±
    [¿¾ ¿ë¾î] À¯µÎ¼±
  • Epiphyseal line
    »À³¡¼±
    [¿¾ ¿ë¾î] °ñ´Ü¼±
  • Incremental line of dentin
    »ó¾ÆÁú¼ºÀå¼±
    [¿¾ ¿ë¾î] »ó¾ÆÁú¼ºÀå¼±
  • Incremental line of cementum
    ½Ã¸àÆ®Áú¼ºÀå¼±
    [¿¾ ¿ë¾î] ½Ã¸àÆ®Áú¼ºÀå¼±
  • Inferior temporal line
    ¾Æ·¡°üÀÚ¼±
    [¿¾ ¿ë¾î] ÇÏÃøµÎ¼±
  • Inferior nuchal line
    ¾Æ·¡¸ñ´ú¹Ì¼±
    [¿¾ ¿ë¾î] ÇÏÇ×(¸ñ´ú¹Ì)¼±
  • Inferior gluteal line
    ¾Æ·¡º¼±â±Ù¼±
    [¿¾ ¿ë¾î] Çϵбټ±
  • Medial supracondylar line
    ¾ÈÂʰüÀýÀ¶±âÀ§¼±
    [¿¾ ¿ë¾î] ³»Ãø°ú»ó¼±
  • Anterior axillary line
    ¾Õ°Üµå¶û¼±
    [¿¾ ¿ë¾î] Àü¾×¿Í¼±
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • low-potential iron protein
    ÀúÀüÀ§ ö´Ü¹éÁú(î¸ï³êÈôÑÓ±ÛÜòõ)
  • low-quality protein
    ÀúÁú´Ü¹éÁú(î¸òõÓ±ÛÜòõ)
  • low-speed sedimentaion equilibrium
    Àú¼Óħ°­ÆòÇü(î¸áÜöØË½øÁû¬)
  • low spin complex
    Àú(î¸)½ºÇÉ º¹ÇÕ¹°(ÜÜùêÚª)
  • low-temperature heat method
    Àú¿Â¿­¹ý(î¸è®æðÛö)
  • very low-density lipoprotein
    ÃÊÀú¹Ðµµ (õ±î¸ÚËÓø) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • very low-lipid lipoprotein
    ÃÊÀúÁöÁú(õ±î¸ò·òõ) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • orbitomeatal [=O-M] line
    ¾È¿ÜÀ̵µ¼±
  • paravertebral line
    ôÃßÁÖÀ§¼±
  • pectineal line
    Ä¡°ñ±Ù¼±
  • prosthesis cement lucent line
    Àΰø¹°½Ã¸àÆ® ¹æ»ç¼ºÅõ°ú¼±
  • reinforcement line
    °­È­¼±
  • waist line
    Ç㸮µÑ·¹, ¿äÀ§
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LIP Lymphoid Interstitial Pneumonia
AEC ankyloblepharon, ectodermal defects, and cleft lip [syndrome]; at earliest convenience; Atomic Energ...
BCLP bilateral cleft of lip and palate
CL/CP cleft lip/cleft palate
CLP chymotrypsin-like protein; cleft lip with cleft palate; paced cycle length
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LIP lateral intraparietal area
LIP lower inflection point
B-LCL B lymphoblastoid cell line
LCL B-lymphoblastoid cell line
BL Base-line
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • low salt syndrome
    Àú¿° ÁõÈıº
  • low silver amalgam
    ÀúÀº ¾Æ¸»°¨
  • low temperature
    Àú¿Â
  • low voltage
    Àú Àü¾Ð
  • low-density lipoprotein
    Àú¹Ðµµ Áö¹æ ´Ü¹é
  • low-frequency wave
    ÀúÁÖÆÄ
  • low-pitched
    ³»¸®±î´Â
  • low-threshold mechanoreceptor
    Àú¿ªÄ¡ ±â°è ¼ö¿ë±â
  • myofascial low back pain
    ±Ù¸·¼º ¿äÅë
    ¿äÅëÀ» ÁַΠȣ¼ÒÇÏ´Â ÁúȯÀÇ ÇϳªÀ̰í ô¼ö ½Å°æÀÌ ¿äºÎ ±Ù¸·À» ¶Õ°í ³ª¿À´Â ºÎÀ§¿¡ ¾ÐÅë ¹× ¿îµ¿ÅëÀÌ ³ªÅ¸³­´Ù. ¿øÀÎÀ¸·Î¼­´Â ±¹¼Ò¿¡¼­ÀÇ ·çĿƼÁò¼³µµ Àִµ¥ ôÃß ºÐ¸®Áõ µî ¿ÜÀÇ ÁúȯÀÎ °æ¿ì¿¡´Â Áõ»óÀ¸·Î ³ªÅ¸³ª´Â ¼öµµ ÀÖ°í °ü·ÃµÇ´Â ÅëÁõ ¿äÀÎÀ̳ª ô¼ö ½Å°æ ÈÄÁöÀÇ Àڱؼº Ç×Áø µîÀ» »ý°¢ÇÒ ¼ö ÀÖ´Ù. Ä¡·á·Î¼­´Â ±¹¼Ò ¸¶ÃëÁ¦³ª ½ºÅ×·ÎÀ̵åÁ¦ÀÇ ±¹¼Ò Áֻ簡 ÀÌ·ç¾îÁö°Å³ª ±Ù¸· Àý°³ ³»Áö ÀýÁ¦¼úÀÌ ÀÌ·ç¾îÁö´Â ¼öµµ ÀÖ´Ù.
  • parakeratotic lip change
    ºÎÀü °¢È­¼º ÀÔ¼ú º¯È­
  • plastic repair on lip
    ±¸¼ø Çü¼º ¼ö¼ú
  • posterior lip
    µÚ ÀÔ¼ú, Èļø
  • single lip change
    ´ÜÀÏ ÀÔ¼ú º¯È­
  • unilateral cleft lip
    ÇÑ ÀÔ¼ú °¥¸²Áõ, ÇÑÂÊ ÀÔ¼ú °¥¸²Áõ
  • upper lip biting habit
    ±³¼øº®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
lip sulcus A furrow between the developing lip and gum.
Synonym: labiodental sulcus, lip sulcus, primary labial groove.
(05 Mar 2000)
lower lip The muscular fold bounding the opening of the mouth inferiorly.
Synonym: labium inferius oris.
(05 Mar 2000)
back pain, low Symptoms in the low back can relate to the bony lumbar spine, discs between the vertebrae, ligaments around the spine and discs, spinal cord and nerves, muscles of the low back, internal organs of the pelvis and abdomen, and the skin covering the lumbar area. The low back, or lumbar area, functions in structural support, movement, and protection of certain body tissue.
(12 Dec 1998)
blood sugar, low The sugar here is glucose. Low blood glucose constitutes hypoglycaemia. Hypoglycaemia is only significant when it is associated with symptoms. It has many causes including drugs, liver disease, surgical absence of the stomach, pre-diabetes, and rare tumours that release excess insulin.
(12 Dec 1998)
cardiac output, low A state of subnormal or depressed cardiac output, usually seen in patients with heart failure secondary to coronary artery, hypertensive, primary myocardial, valvular, or pericardial disease.
(12 Dec 1998)
very low density lipoprotein <biochemistry> A lipoprotein substances (combination of a fat and a protein) which acts as a carrier for cholesterol and fats (particularly triglycerides) in the bloodstream.
Elevations in very low density lipoprotein in the bloodstream are associated with an increased risk of atherosclerosis and coronary artery disease.
Acronym: VLDL
(18 Nov 1997)
Castellani-Low sign <clinical sign> A fine tremor of the tongue observed in sleeping sickness.
(05 Mar 2000)
mean lower low water <marine biology> The average height of the lower low waters over a 19-year period. For shorter periods of observations, corrections are applied to eliminate known variations and reduce the result to the equivalent of a mean 19-year value.
(09 Oct 1997)
mean low water <marine biology> The average height of the low waters over a 19-year period. For shorter periods of observations, corrections are applied to eliminate known variations and reduce the result to the equivalent of a mean 19-year value.
All low-water heights are included in the average where the type of tide is either semidiurnal or mixed. Only the lower low-water heights are included in the average where the type of tide is diurnal. So determined, mean low water in the latter case is the same as mean lower low water.
(09 Oct 1997)
placenta, low Location of the placenta in the lower part of the uterus (womb) so that the placenta partially or completely covers the cervix. Also known as a placenta previa.
(12 Dec 1998)
heparin, low-molecular-weight <chemical> Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of haemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.
Pharmacological action: anticoagulant, fibrinolytic agent.
(12 Dec 1998)
infant, low birth weight An infant having a birth weight of 2500 gm. (5.5 lb.) or less but infant, very low birth weight is available for infants having a birth weight of 1500 grams (3.3 lb.) or less.
(12 Dec 1998)
infant, very low birth weight An infant having a birth weight of 1500 grams (3.3 lb.) or less.
(12 Dec 1998)
ear, low-set A minor anomaly involving an ear situated down below its normal location. Technically, the ear is low-set when the helix (of the ear) meets the cranium at a level below that of a horizontal plane through both inner canthi (the inside corners of the eyes). The presence of 2 or more minor anomalies in a child increases the probability that the child has a major malformation.
(12 Dec 1998)
kininogen, low-molecular-weight A protein, molecular weight 50 kD, located in various normal tissues. Upon cleavage by kallikrein or other kallikreins, it forms kallidin. Kallidin, in turn, is converted into bradykinin.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • air-line
    °ø·Î¿¡ ÀÇÇÑ
  • bottom line
    °á°ú, ¼øÀÌÀÍ
  • by-line
    À̸§ÀÌ ¾º¾îÀÖ´Â Çà
  • in line with
    -¿Í ÀÏÄ¡ÇÏ¿©
  • line
    ¼±,¿­,³ª¶õÀÌÇÏ´Ù
  • main line
    °£¼±
  • two-line
    ¹èÇüÀÇ
  • A line
    ¶óÀÎÀÇ;A¶óÀÎÀÇ(¿©¼ºº¹ÀÌ AÀÚó·³ À§°¡ Á¼°í ¹ØÀÌ ÆÛÁü)
  • DEW line
    µà¶óÀÎ(ºÏ±Ø±Ç ºÏºÎ¿¡ ÀÖ´Â ¹Ì±¹.ij³ª´Ù °øµ¿ÀÇ ¿ø°Å¸®Á¶±â °æº¸¸Á)
  • Distant Early Warning line
    =DEW LINE
  • Gray Line
    ¹Ì±¹ÀÇ ´ë±Ô¸ð °ü±¤¹ö½º ȸ»ç
  • International Date Line
    ±¹Á¦ ³¯Â¥ º¯°æ¼±(IDL)
  • Mason Dixon line
    MarylandÁÖ¿Í PennsylvaniaÁÖÀÇ °æ°è¼±(³ë¿¹ ½Ã´ëÀÇ ³²ºÏ °æ°è¼±,ÇöÀç´Â ¹æ¾ð ±¸ºÐ¼±ÀÇ Çϳª)
  • Siegfried Line
    ÁöÅ©ÇÁ¸®Æ®¼±;Á¦ 2Â÷ ´ëÀü¿¡ ¾Õ¼­ µ¶ÀÏÀÌ ±¸ÃàÇÑ ¼­ºÎÀÏ´ëÀÇ ¿ä»õ¼±
  • assembly line
    ÀϰüÀÛ¾÷Á¶Á÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á